Clinical trial
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate…
NCT00003645 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00003645 |
|---|---|
| Title | Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence |
| Official title | A Phase III Randomized Prospective Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group AstraZeneca Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Flutamide, Leuprolide Acetate |
| Enrollment | 64 |
| Start date | Jun 14, 1999 |
| Primary completion | Mar 20, 2017 |
| Completion | Mar 20, 2017 |
| First posted | Jul 15, 2003 |
| Last update posted | Apr 28, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: